Prevention of Ovarian Damage and Infertility in Young Female Cancer Patients Awaiting Chemotherapy--clinical Approach and Unsolved Issues

Overview

Journal Support Care Cancer

Specialties Critical Care
Oncology

Date 2011 Sep 28

PMID 21947410

Citations 2

Authors

Katharina Hancke

Vladimir Isachenko

Evgenia Isachenko

Jurgen M Weiss

Affiliations

Soon will be listed here.

Abstract

Great advances in the oncological therapy of childhood and adolescent cancer patients lead to an increase of young cancer survivors with a normal expectancy of life. The aggressive chemotherapy and/or radiation often compromises endocrine function with consecutive menopausal symptoms and sterility. Recently, new approaches were developed to preserve fertility with different methods to restore the ovarian function. The present review gives an overview of the current possibilities, which may be offered to these young cancer patients, as well as the chances of success and risks and the unsolved issues in special situations.

Citing Articles

Fertility preservation in women with ovarian cancer: Finding new pathways: A case-control study.

Khodadadian A, Varghaiyan Y, Babakhanzadeh E, Alipourfard I, Haghi-Daredeh S, Ghobadi A Int J Reprod Biomed. 2021; 19(2):157-166.

PMID: 33718760 PMC: 7922293. DOI: 10.18502/ijrm.v19i2.8474.

Fertility-sparing surgery in early epithelial ovarian cancer: a viable option?.

Fotopoulou C, Braicu I, Sehouli J Obstet Gynecol Int. 2012; 2012:238061.

PMID: 22529854 PMC: 3316954. DOI: 10.1155/2012/238061.

References

Groome N, Illingworth P, OBrien M, Cooke I, Ganesan T, Baird D . Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol (Oxf). 1994; 40(6):717-23. DOI: 10.1111/j.1365-2265.1994.tb02504.x. View

Lobo R . Potential options for preservation of fertility in women. N Engl J Med. 2005; 353(1):64-73. DOI: 10.1056/NEJMra043475. View

Bittinger S, Nazaretian S, Gook D, Parmar C, Harrup R, Stern C . Detection of Hodgkin lymphoma within ovarian tissue. Fertil Steril. 2010; 95(2):803.e3-6. DOI: 10.1016/j.fertnstert.2010.07.1068. View

Del Mastro L, Catzeddu T, Boni L, Bell C, Sertoli M, Bighin C . Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann Oncol. 2005; 17(1):74-8. DOI: 10.1093/annonc/mdj029. View

Roche H, Kerbrat P, Bonneterre J, Fargeot P, Fumoleau P, Monnier A . Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial. Ann Oncol. 2006; 17(8):1221-7. DOI: 10.1093/annonc/mdl107. View

. A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes. Cancer Res. 1985; 45(9):4454-9. View

Demeestere I, Simon P, Buxant F, Robin V, Fernandez S, Centner J . Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Hum Reprod. 2006; 21(8):2010-4. DOI: 10.1093/humrep/del092. View

von Wolff M, Thaler C, Frambach T, Zeeb C, Lawrenz B, Popovici R . Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril. 2008; 92(4):1360-1365. DOI: 10.1016/j.fertnstert.2008.08.011. View

Griesinger G, Diedrich K, Devroey P, Kolibianakis E . GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update. 2005; 12(2):159-68. DOI: 10.1093/humupd/dmi045. View

10.

Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y . Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med. 2005; 353(3):318-21. DOI: 10.1056/NEJMc055237. View

11.

Donnez J, Dolmans M, Demylle D, Jadoul P, Pirard C, Squifflet J . Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004; 364(9443):1405-10. DOI: 10.1016/S0140-6736(04)17222-X. View

12.

Barritt J, Luna M, Duke M, Grunfeld L, Mukherjee T, Sandler B . Report of four donor-recipient oocyte cryopreservation cycles resulting in high pregnancy and implantation rates. Fertil Steril. 2006; 87(1):189.e13-7. DOI: 10.1016/j.fertnstert.2006.04.052. View

13.

Oktay K . Ovarian tissue cryopreservation and transplantation: preliminary findings and implications for cancer patients. Hum Reprod Update. 2001; 7(6):526-34. DOI: 10.1093/humupd/7.6.526. View

14.

Cobo A, Bellver J, Domingo J, Perez S, Crespo J, Pellicer A . New options in assisted reproduction technology: the Cryotop method of oocyte vitrification. Reprod Biomed Online. 2008; 17(1):68-72. DOI: 10.1016/s1472-6483(10)60295-7. View

15.

Diedrich K, Diedrich C, Santos E, Zoll C, Al-Hasani S, Reissmann T . Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod. 1994; 9(5):788-91. DOI: 10.1093/oxfordjournals.humrep.a138597. View

16.

Castiglione-Gertsch M, ONeill A, Price K, Goldhirsch A, Coates A, Colleoni M . Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial. J Natl Cancer Inst. 2003; 95(24):1833-46. DOI: 10.1093/jnci/djg119. View

17.

Sanchez-Serrano M, Crespo J, Mirabet V, Cobo A, Escriba M, Simon C . Twins born after transplantation of ovarian cortical tissue and oocyte vitrification. Fertil Steril. 2009; 93(1):268.e11-3. DOI: 10.1016/j.fertnstert.2009.09.046. View

18.

Meirow D, Epstein M, Lewis H, Nugent D, Gosden R . Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod. 2001; 16(4):632-7. DOI: 10.1093/humrep/16.4.632. View

19.

Cobo A, Vajta G, Remohi J . Vitrification of human mature oocytes in clinical practice. Reprod Biomed Online. 2009; 19 Suppl 4:4385. View

20.

Behringer K, Wildt L, Mueller H, Mattle V, Ganitis P, van den Hoonaard B . No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group. Ann Oncol. 2010; 21(10):2052-2060. DOI: 10.1093/annonc/mdq066. View